GE Healthymagination backed NanoString Technologies, a company which makes life sciences research tools and molecular diagnostics, has raised $275,000 through an offering of rights and securities, as shown in a recent filing.
Last month, the company closed a $15.3m Series E round from investors including Investment management company AllianceBernstein Alternative Management Group, and venture fims BioMed Ventures, Clarus Ventures, Draper Fisher Jurvetson, GE Healthymagination, Morgan Stanley Expansion Capital and OVP Venture Partners.
NanoString Technologies closed its series D funding round in November last year, having raised $20m from a pool of investors including GE Capital, which acts as the private equity investment unit for energy conglomerate General Electric.